Notice of Funding Opportunity Purpose
National Institutes of Health
Description
This grant opportunity invites applications focused on developing new treatments for mental disorders through preclinical research and proof of concept testing of innovative agents and neurostimulation methods. It encourages collaboration between academic institutions and industry to create multidisciplinary, long-term projects aimed at significant research goals. The grant also supports the development of novel diagnostic tools, wearable devices, and validation of drug or device targets. Ap…
This NOFO encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders and to develop novel ligands and circuit-engagement devices as tools to furt…
Source
Grant ID
PAR-25-353
Agency
National Institutes of Health
Subcategory/Subagency
National Institute of Mental Health
Key Dates
Opportunity Released
January 15, 2025
Eligibility
The following categories of applicants are invited to apply:
- Public/State Controlled Institutions of Higher Education
- Private Institutions of Higher Education
- Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Small Businesses
- For-Profit Organizations (Other than Small Businesses)
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Eligible Agencies of the Federal Government
- U.S. Territory or Possession
- Independent School Districts
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Faith-based or Community-based Organizations
- Regional Organizations
- Public Housing Authorities/Indian Housing Authorities
Similar opportunities
- Accelerating Innovative Drug and Device Therapies Translation from Discovery to Early Human Studies
National Institutes of Health
- Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics): Biologics-based Therapy Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
National Institutes of Health
- Blueprint Neurotherapeutics Network for Biologics (BPN Biologics)
National Institutes of Health
- Facilitating the Translation of Novel Recording and Modulation Technologies for CNS Disorders
National Institutes of Health
- Notice of Funding Opportunity Purpose
National Institutes of Health